PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE ULCERATIVE COLITIS PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer  1     Sandra Plachta-Danielzik  2     Romina di Giuseppe  2     Philipp Efken  3     Wolfgang Mohl  4     Thomas Krause  5     Martin Hoffstadt  6     Robert Ehehalt  7     Leo Trentmann  8     Axel Schweitzer  9     Petra Jessen  10     Sina Franzenburg  10     Petra Hartmann  10     Stefan Schreiber  11    
1 Interdisciplinary Crohn Colitis Centre Minden, Minden, Germany
2 Competence Network IBD, Kiel, Germany
3 Gastroenterology Practice Minden, Minden, Germany
4 Zentrum fur Gastroenterologie Saar MVZ GmbH, Saarbrücken, Germany
5 Gastroenterology Practice Opernstraße, Kassel, Germany
6 Medizinisches Versorgungszentrum Dres. Hoffstadt, Iserlohn, Germany
7 Praxis für Gastroenterologie Prof. Dr. R. Ehehalt, Heidelberg, Germany
8 Gastroenterology Practice Bremen, Bremen, Germany
9 Gastroenterologische Gemeinschaftspraxis am Germania Campus, Münster, Germany
10 Gastroenterology Practice Kiel, Altenholz, Germany
11 Universität Kiel UKSH Medizinische Abt. I, Kiel, Germany

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing